According to Sutro Biopharma's latest financial reports the company's current EPS (TTM) is -$3.93. In 2022 the company made an earnings per share (EPS) of -$3.77 a decrease over its 2021 EPS that were of -$3.64.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.70 | -1.87% |
2022 | -$3.77 | 3.49% |
2021 | -$3.64 | 78.91% |
2020 | -$2.03 | -47.11% |
2019 | -$3.85 | -12.2% |
2018 | -$4.38 |